TY - JOUR AU - Maurer, T. AU - Eiber, M. PY - 2019 DA - 2019// TI - Practice changing for prostate cancer: a vision of the future JO - Nat Rev Urol VL - 16 UR - https://doi.org/10.1038/s41585-018-0134-6 DO - 10.1038/s41585-018-0134-6 ID - Maurer2019 ER - TY - JOUR AU - Fanti, S. AU - Minozzi, S. AU - Antoch, G. AU - Banks, I. AU - Briganti, A. AU - Carrio, I. PY - 2018 DA - 2018// TI - Consensus on molecular imaging and theranostics in prostate cancer JO - Lancet Oncol VL - 19 UR - https://doi.org/10.1016/S1470-2045(18)30604-1 DO - 10.1016/S1470-2045(18)30604-1 ID - Fanti2018 ER - TY - JOUR AU - Hofman, M. S. AU - Lawrentschuk, N. AU - Francis, R. J. AU - Tang, C. AU - Vela, I. AU - Thomas, P. PY - 2020 DA - 2020// TI - Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study JO - Lancet VL - 395 UR - https://doi.org/10.1016/S0140-6736(20)30314-7 DO - 10.1016/S0140-6736(20)30314-7 ID - Hofman2020 ER - TY - JOUR AU - Eder, M. AU - Schafer, M. AU - Bauder-Wust, U. AU - Hull, W. E. AU - Wangler, C. AU - Mier, W. PY - 2012 DA - 2012// TI - 68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging JO - Bioconjug Chem VL - 23 UR - https://doi.org/10.1021/bc200279b DO - 10.1021/bc200279b ID - Eder2012 ER - TY - JOUR AU - Afshar-Oromieh, A. AU - Malcher, A. AU - Eder, M. AU - Eisenhut, M. AU - Linhart, H. G. AU - Hadaschik, B. A. PY - 2013 DA - 2013// TI - PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions JO - Eur J Nucl Med Mol Imaging VL - 40 UR - https://doi.org/10.1007/s00259-012-2298-2 DO - 10.1007/s00259-012-2298-2 ID - Afshar-Oromieh2013 ER - TY - JOUR AU - Afshar-Oromieh, A. AU - Avtzi, E. AU - Giesel, F. L. AU - Holland-Letz, T. AU - Linhart, H. G. AU - Eder, M. PY - 2015 DA - 2015// TI - The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer JO - Eur J Nucl Med Mol Imaging VL - 42 UR - https://doi.org/10.1007/s00259-014-2949-6 DO - 10.1007/s00259-014-2949-6 ID - Afshar-Oromieh2015 ER - TY - JOUR AU - Eiber, M. AU - Maurer, T. AU - Souvatzoglou, M. AU - Beer, A. J. AU - Ruffani, A. AU - Haller, B. PY - 2015 DA - 2015// TI - Evaluation of hybrid68 Ga-PSMA ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy JO - J Nucl Med VL - 56 UR - https://doi.org/10.2967/jnumed.115.154153 DO - 10.2967/jnumed.115.154153 ID - Eiber2015 ER - TY - JOUR AU - Fendler, W. P. AU - Eiber, M. AU - Beheshti, M. AU - Bomanji, J. AU - Ceci, F. AU - Cho, S. PY - 2017 DA - 2017// TI - (68)Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0 JO - Eur J Nucl Med Mol Imaging VL - 44 UR - https://doi.org/10.1007/s00259-017-3670-z DO - 10.1007/s00259-017-3670-z ID - Fendler2017 ER - TY - JOUR AU - Perera, M. AU - Papa, N. AU - Christidis, D. AU - Wetherell, D. AU - Hofman, M. S. AU - Murphy, D. G. PY - 2016 DA - 2016// TI - Sensitivity, specificity, and predictors of positive (68)Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis JO - Eur Urol VL - 70 UR - https://doi.org/10.1016/j.eururo.2016.06.021 DO - 10.1016/j.eururo.2016.06.021 ID - Perera2016 ER - TY - JOUR AU - Sanchez-Crespo, A. PY - 2013 DA - 2013// TI - Comparison of Gallium-68 and Fluorine-18 imaging characteristics in positron emission tomography JO - Applied radiation and isotopes: including data, instrumentation and methods for use in agriculture, industry and medicine VL - 76 UR - https://doi.org/10.1016/j.apradiso.2012.06.034 DO - 10.1016/j.apradiso.2012.06.034 ID - Sanchez-Crespo2013 ER - TY - JOUR AU - Kesch, C. AU - Kratochwil, C. AU - Mier, W. AU - Kopka, K. AU - Giesel, F. L. PY - 2017 DA - 2017// TI - (68)Ga or (18)F for prostate cancer imaging? JO - J Nucl Med VL - 58 UR - https://doi.org/10.2967/jnumed.117.190157 DO - 10.2967/jnumed.117.190157 ID - Kesch2017 ER - TY - JOUR AU - Rahbar, K. AU - Weckesser, M. AU - Ahmadzadehfar, H. AU - Schäfers, M. AU - Stegger, L. AU - Bögemann, M. PY - 2018 DA - 2018// TI - Advantage of (18)F-PSMA-1007 over (68)Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion JO - Eur J Nucl Med Mol Imaging. VL - 45 UR - https://doi.org/10.1007/s00259-018-3952-0 DO - 10.1007/s00259-018-3952-0 ID - Rahbar2018 ER - TY - JOUR AU - Dietlein, M. AU - Kobe, C. AU - Kuhnert, G. AU - Stockter, S. AU - Fischer, T. AU - Schomacker, K. PY - 2015 DA - 2015// TI - Comparison of [(18)F]DCFPyL and [(68)Ga]Ga-PSMA-HBED-CC for PSMA-PET imaging in patients with relapsed prostate cancer JO - Mol Imaging Biol VL - 17 UR - https://doi.org/10.1007/s11307-015-0866-0 DO - 10.1007/s11307-015-0866-0 ID - Dietlein2015 ER - TY - JOUR AU - Werner, R. A. AU - Derlin, T. AU - Lapa, C. AU - Sheikbahaei, S. AU - Higuchi, T. AU - Giesel, F. L. PY - 2020 DA - 2020// TI - (18)F-Labeled, PSMA-targeted radiotracers: leveraging the advantages of radiofluorination for prostate cancer molecular imaging JO - Theranostics VL - 10 UR - https://doi.org/10.7150/thno.37894 DO - 10.7150/thno.37894 ID - Werner2020 ER - TY - JOUR AU - Wurzer, A. AU - Carlo, D. AU - Schmidt, A. AU - Beck, R. AU - Eiber, M. AU - Schwaiger, M. PY - 2020 DA - 2020// TI - Radiohybrid ligands: a novel tracer concept exemplified by (18)F- or (68)Ga-labeled rhPSMA inhibitors JO - J Nucl Med VL - 61 UR - https://doi.org/10.2967/jnumed.119.234922 DO - 10.2967/jnumed.119.234922 ID - Wurzer2020 ER - TY - JOUR AU - Eiber, M. AU - Kroenke, M. AU - Wurzer, A. AU - Ulbrich, L. AU - Jooß, L. AU - Maurer, T. PY - 2020 DA - 2020// TI - (18)F-rhPSMA-7 PET for the detection of biochemical recurrence of prostate cancer after radical prostatectomy JO - J Nucl Med VL - 61 UR - https://doi.org/10.2967/jnumed.119.234914 DO - 10.2967/jnumed.119.234914 ID - Eiber2020 ER - TY - JOUR AU - Kroenke, M. AU - Wurzer, A. AU - Schwamborn, K. AU - Ulbrich, L. AU - Jooß, L. AU - Maurer, T. PY - 2020 DA - 2020// TI - Histologically confirmed diagnostic efficacy of (18)F-rhPSMA-7 PET for N-staging of patients with primary high-risk prostate cancer JO - J Nucl Med VL - 61 UR - https://doi.org/10.2967/jnumed.119.234906 DO - 10.2967/jnumed.119.234906 ID - Kroenke2020 ER - TY - JOUR AU - Oh, S. W. AU - Wurzer, A. AU - Teoh, E. J. AU - Oh, S. AU - Langbein, T. AU - Krönke, M. PY - 2020 DA - 2020// TI - Quantitative and qualitative analyses of biodistribution and PET image quality of a novel radiohybrid PSMA, (18)F-rhPSMA-7, in patients with prostate cancer JO - J Nucl Med VL - 61 UR - https://doi.org/10.2967/jnumed.119.234609 DO - 10.2967/jnumed.119.234609 ID - Oh2020 ER - TY - JOUR AU - Robu, S. AU - Schmidt, A. AU - Eiber, M. AU - Schottelius, M. AU - Gunther, T. AU - Hooshyar Yousefi, B. PY - 2018 DA - 2018// TI - Synthesis and preclinical evaluation of novel (18)F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with (18)F-DCFPyl and (18)F-PSMA-1007 JO - EJNMMI Res VL - 8 UR - https://doi.org/10.1186/s13550-018-0382-8 DO - 10.1186/s13550-018-0382-8 ID - Robu2018 ER - TY - JOUR AU - Iovkova, L. AU - Wängler, B. AU - Schirrmacher, E. AU - Schirrmacher, R. AU - Quandt, G. AU - Boening, G. PY - 2009 DA - 2009// TI - para-Functionalized Aryl-di-tert-butylfluorosilanes as potential labeling synthons for 18F radiopharmaceuticals JO - Chem Eur J VL - 15 UR - https://doi.org/10.1002/chem.200802266 DO - 10.1002/chem.200802266 ID - Iovkova2009 ER - TY - JOUR AU - Valko, K. AU - Nunhuck, S. AU - Bevan, C. AU - Abraham, M. H. AU - Reynolds, D. P. PY - 2003 DA - 2003// TI - Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity JO - J Pharm Sci VL - 92 UR - https://doi.org/10.1002/jps.10494 DO - 10.1002/jps.10494 ID - Valko2003 ER - TY - JOUR AU - Wessmann, S. H. AU - Henriksen, G. AU - Wester, H. J. PY - 2012 DA - 2012// TI - Cryptate mediated nucleophilic 18F-fluorination without azeotropic drying JO - Nuklearmed Nucl Med VL - 51 UR - https://doi.org/10.3413/Nukmed-0425-11-08 DO - 10.3413/Nukmed-0425-11-08 ID - Wessmann2012 ER - TY - JOUR AU - Chen, Y. AU - Pullambhatla, M. AU - Foss, C. A. AU - Byun, Y. AU - Nimmagadda, S. AU - Senthamizhchelvan, S. PY - 2011 DA - 2011// TI - 2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pen tanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-11-1357 DO - 10.1158/1078-0432.CCR-11-1357 ID - Chen2011 ER - TY - JOUR AU - Gorin, M. A. AU - Rowe, S. P. AU - Patel, H. D. AU - Vidal, I. AU - Mana-Ay, M. AU - Javadi, M. S. PY - 2018 DA - 2018// TI - Prostate specific membrane antigen targeted (18)F-DCFPyL positron emission tomography/computerized tomography for the preoperative staging of high risk prostate cancer: results of a prospective, phase II JO - Single Center Study J Urol VL - 199 ID - Gorin2018 ER - TY - JOUR AU - Cardinale, J. AU - Schafer, M. AU - Benesova, M. AU - Bauder-Wust, U. AU - Leotta, K. AU - Eder, M. PY - 2017 DA - 2017// TI - Preclinical evaluation of (18)F-PSMA-1007, a new prostate-specific membrane antigen ligand for prostate cancer imaging JO - J Nucl Med VL - 58 UR - https://doi.org/10.2967/jnumed.116.181768 DO - 10.2967/jnumed.116.181768 ID - Cardinale2017 ER - TY - JOUR AU - Giesel, F. L. AU - Hadaschik, B. AU - Cardinale, J. AU - Radtke, J. AU - Vinsensia, M. AU - Lehnert, W. PY - 2017 DA - 2017// TI - F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients JO - Eur J Nucl Med Mol Imaging VL - 44 UR - https://doi.org/10.1007/s00259-016-3573-4 DO - 10.1007/s00259-016-3573-4 ID - Giesel2017 ER - TY - JOUR AU - Han, Y. AU - Albericio, F. AU - Barany, G. PY - 1997 DA - 1997// TI - Occurrence and minimization of cysteine racemization during stepwise solid-phase peptide synthesis JO - J Org Chem VL - 62 UR - https://doi.org/10.1021/jo9622744 DO - 10.1021/jo9622744 ID - Han1997 ER - TY - JOUR AU - Evans, B. J. AU - King, A. T. AU - Katsifis, A. AU - Matesic, L. AU - Jamie, J. F. PY - 2020 DA - 2020// TI - Methods to enhance the metabolic stability of peptide-based PET radiopharmaceuticals JO - Molecules VL - 25 UR - https://doi.org/10.3390/molecules25102314 DO - 10.3390/molecules25102314 ID - Evans2020 ER - TY - JOUR AU - Weineisen, M. AU - Simecek, J. AU - Schottelius, M. AU - Schwaiger, M. AU - Wester, H. J. PY - 2014 DA - 2014// TI - Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer JO - EJNMMI Res VL - 4 UR - https://doi.org/10.1186/s13550-014-0063-1 DO - 10.1186/s13550-014-0063-1 ID - Weineisen2014 ER - TY - JOUR AU - Schirrmacher, R. AU - Bradtmoller, G. AU - Schirrmacher, E. AU - Thews, O. AU - Tillmanns, J. AU - Siessmeier, T. PY - 2006 DA - 2006// TI - 18F-labeling of peptides by means of an organosilicon-based fluoride acceptor JO - Angew Chem Int Ed Engl VL - 45 UR - https://doi.org/10.1002/anie.200600795 DO - 10.1002/anie.200600795 ID - Schirrmacher2006 ER - TY - JOUR AU - Kostikov, A. P. AU - Iovkova, L. AU - Chin, J. AU - Schirrmacher, E. AU - Wängler, B. AU - Wängler, C. PY - 2011 DA - 2011// TI - N-(4-(di-tert-butyl[18F]fluorosilyl)benzyl)-2-hydroxy-N, N-dimethylethylammonium bromide ([18F]SiFAN+Br−): a novel lead compound for the development of hydrophilic SiFA-based prosthetic groups for 18F-labeling JO - J Fluor Chem VL - 132 UR - https://doi.org/10.1016/j.jfluchem.2010.10.008 DO - 10.1016/j.jfluchem.2010.10.008 ID - Kostikov2011 ER - TY - JOUR AU - Ghibellini, G. AU - Leslie, E. M. AU - Brouwer, K. L. PY - 2006 DA - 2006// TI - Methods to evaluate biliary excretion of drugs in humans: an updated review JO - Mol Pharm VL - 3 UR - https://doi.org/10.1021/mp060011k DO - 10.1021/mp060011k ID - Ghibellini2006 ER - TY - JOUR AU - Kratochwil, N. A. AU - Huber, W. AU - Muller, F. AU - Kansy, M. AU - Gerber, P. R. PY - 2002 DA - 2002// TI - Predicting plasma protein binding of drugs: a new approach JO - Biochem Pharmacol VL - 64 UR - https://doi.org/10.1016/S0006-2952(02)01074-2 DO - 10.1016/S0006-2952(02)01074-2 ID - Kratochwil2002 ER - TY - JOUR AU - Jadvar, H. AU - Desai, B. AU - Conti, P. S. PY - 2015 DA - 2015// TI - Sodium 18F-fluoride PET/CT of bone, joint, and other disorders JO - Semin Nucl Med VL - 45 UR - https://doi.org/10.1053/j.semnuclmed.2014.07.008 DO - 10.1053/j.semnuclmed.2014.07.008 ID - Jadvar2015 ER -